Literature DB >> 12394945

Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.

Catherine S C Bouman1, Heleen M Oudemans-Van Straaten, Jan G P Tijssen, Durk F Zandstra, Jozef Kesecioglu.   

Abstract

OBJECTIVE: To study the effects of the initiation time of continuous venovenous hemofiltration and of the ultrafiltrate rate in patients with circulatory and respiratory insufficiency developing early oliguric acute renal failure. The primary end points were mortality at 28 days and recovery of renal function.
DESIGN: A randomized, controlled, two-center study.
SETTING: The closed-format multidisciplinary intensive care units of a university hospital (30 beds) and a teaching hospital (18 beds). PATIENTS AND
INTERVENTIONS: A total of 106 ventilated severely ill patients who were oliguric despite massive fluid resuscitation, inotropic support, and high-dose intravenous diuretics were randomized into three groups. Thirty-five patients were treated with early high-volume hemofiltration (72-96 L per 24 hrs), 35 patients with early low-volume hemofiltration (24-36 L per 24 hrs), and 36 patients with late low-volume hemofiltration (24-36 L per 24 hrs).
RESULTS: Median ultrafiltrate rate was 48.2 (42.3-58.7) mL.kg(-1).hr(-1) in early high-volume hemofiltration, 20.1 (17.5-22.0) mL.kg(-1).hr(-1) in early low-volume hemofiltration, and 19.0 (16.6-21.1) mL.kg(-1).hr(-1) in late low-volume hemofiltration. Survival at day 28 was 74.3% in early high-volume hemofiltration, 68.8% in early low-volume hemofiltration, and 75.0% in late low-volume hemofiltration (p =.80). On average, hemofiltration started 7 hrs after inclusion in the early groups and 42 hrs after inclusion in the late group. All hospital survivors had recovery of renal function at hospital discharge, except for one patient in the early low-volume hemofiltration group. Median duration of renal failure in hospital survivors was 4.3 (1.4-7.8) days in early high-volume hemofiltration, 3.2 (2.4-5.4) days in early low-volume hemofiltration, and 5.6 (3.1-8.5) days in late low-volume hemofiltration (p =.25).
CONCLUSIONS: In the present study of critically ill patients with oliguric acute renal failure, survival at 28 days and recovery of renal function were not improved using high ultrafiltrate volumes or early initiation of hemofiltration.

Entities:  

Mesh:

Year:  2002        PMID: 12394945     DOI: 10.1097/00003246-200210000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  150 in total

Review 1.  Effluent volume and dialysis dose in CRRT: time for reappraisal.

Authors:  Etienne Macedo; Rolando Claure-Del Granado; Ravindra L Mehta
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

Review 2.  The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2010-04-10       Impact factor: 2.370

3.  Weekend hospital admission, acute kidney injury, and mortality.

Authors:  Matthew T James; Ron Wald; Chaim M Bell; Marcello Tonelli; Brenda R Hemmelgarn; Sushrut S Waikar; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2010-04-15       Impact factor: 10.121

Review 4.  Continuous renal replacement therapy: recent advances and future research.

Authors:  John R Prowle; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

5.  Does early-start renal replacement therapy improve outcomes for patients with acute kidney injury?

Authors:  John R Prowle; Andrew Davenport
Journal:  Kidney Int       Date:  2015-10       Impact factor: 10.612

6.  Does this patient with AKI need RRT?

Authors:  Miet Schetz; Lui G Forni; Michael Joannidis
Journal:  Intensive Care Med       Date:  2015-12-21       Impact factor: 17.440

7.  Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Carola Cademartiri; Aderville Cabassi; Edoardo Picetti; Maria Barbagallo; Tiziano Gherli; Giuseppe Castellano; Santo Morabito; Umberto Maggiore
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

Review 8.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

Review 9.  Discontinuation of renal replacement therapy in critically ill patients with severe acute kidney injury: predictive factors of renal function recovery.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2018-08-02       Impact factor: 2.370

Review 10.  Renal cell therapy and beyond.

Authors:  Joon Ho Song; H David Humes
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.